Get started
Author

Luis Gerardo Rodríguez‐Lobato

Observed names: Gerardo Rodríguez, L. G. Rodríguez-Lobato, L.G. Rodríguez-Lobato, Luis G. Rodríguez-Lobato, Luis G. Rodríguez‐Lobato, Luis Gerardo Rodríguez-Lobato, Luis Gerardo Rodriguez-Lobato, Luis Gerardo Rodríguez Lobato, Luis Gerardo Rodríguez-Lobato, Luis-Gerardo Rodríguez-Lobato, Luís Gerardo Rodríguez-Lobato, Rodríguez Lobato, Luis Gerardo, Rodríguez-Lobato Luis Gerardo, Rodríguez-Lobato, Luis Gerardo
Observed institutions: Josep Carreras Leukaemia Research Institute, Hospital Clínic de Barcelona, Universitätsklinikum Würzburg, Centro Médico ABC, Instituto Nacional de Cardiología, Fundació Clínic per a la Recerca Biomèdica, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona
ORCID: 0000-0001-5694-0921
Observed ORCID: 0000-0001-5694-0921
OpenAlex ID: A5028420062
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study
2023 · Aina Oliver-Caldés, Verónica González-Calle, et al. · The Lancet Oncology · 98
PDF
CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions
2020 · Luis Gerardo Rodríguez-Lobato, Maya Ganzetti, et al. · Frontiers in Oncology · 83
PDF
Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure
2021 · Mireia Uribe-Herranz, Nela Klein-González, et al. · International Journal of Molecular Sciences · 81
PDF
Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression
2018 · Carlos Fernández de Larrea, Ignacio Isola, et al. · Leukemia · 67
Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation
2023 · Alexandra Pedraza, María Queralt Salas, et al. · Transplantation and Cellular Therapy · 60
PDF
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma
2021 · Benedetto Bruno, Ralph Wäsch, et al. · Haematologica · 48
PDF
First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma
2021 · Aina Oliver-Caldes, Raquel Jiménez, et al. · Journal for ImmunoTherapy of Cancer · 47
PDF
Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma
2020 · Ester Lozano, Mari-Pau Mena, et al. · Clinical Cancer Research · 47
PDF
Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant
2022 · Amanda Isabel Pérez-Valencia, Enric Cascos, et al. · Blood Advances · 39
PDF
Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution
2022 · Raquel Jiménez-Segura, Laura Rosiñol, et al. · Blood Cancer Journal · 39
PDF
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells
2022 · Estefanía García-Guerrero, Luis G. Rodríguez-Lobato, et al. · Haematologica · 34
PDF
Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis
2020 · Gonzalo Gutiérrez-García, Jesús Villarreal, et al. · Bone Marrow Transplantation · 30
A reproducible and safe at-home allogeneic haematopoietic cell transplant program: first experience in Central and Southern Europe
2020 · Gonzalo Gutiérrez-García, Montserrat Rovira, et al. · Bone Marrow Transplantation · 30
Complement as the enabler of carfilzomib‐induced thrombotic microangiopathy
2020 · Miquel Blasco, Alexandra Martínez‐Roca, et al. · British Journal of Haematology · 29
PDF
Bone marrow plasma cell infiltration in light chain amyloidosis: impact on organ involvement and outcome
2018 · Natalia Tovar, Luis Gerardo Rodríguez-Lobato, et al. · Amyloid · 28
Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia
2022 · David F. Moreno, Mónica López‐Guerra, et al. · British Journal of Haematology · 27
PDF
Factors associated with the clinical outcome of patients with relapsed/refractory CD19+ acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy
2021 · Valentín Ortiz-Maldonado, Susana Rives, et al. · Journal for ImmunoTherapy of Cancer · 27
PDF
Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation
2018 · Gonzalo Gutiérrez-García, Montserrat Rovira, et al. · Bone Marrow Transplantation · 27
Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma
2018 · Ester Lozano, Tania Díaz, et al. · The Journal of Immunology · 26
Risk Factors for Mortality in Hematopoietic Stem Cell Transplantation Recipients with Bloodstream Infection: Points To Be Addressed by Future Guidelines
2021 · Pedro Puerta-Alcalde, Mariana Chumbita, et al. · Transplantation and Cellular Therapy · 25
The academic point‐of‐care anti‐CD19 chimeric antigen receptor T‐cell product varnimcabtagene autoleucel ( ARI ‐0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B‐cell non‐Hodgkin lymphoma
2023 · Núria Martínez‐Cibrián, Valentín Ortiz‐Maldonado, et al. · British Journal of Haematology · 24
PDF
Results of ARI ‐0001 CART19 cell therapy in patients with relapsed/refractory CD19 ‐positive acute lymphoblastic leukemia with isolated extramedullary disease
2022 · Valentín Ortiz‐Maldonado, Anna Alonso‐Saladrigues, et al. · American Journal of Hematology · 24
Effect of CD34+ Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide
2022 · Alexandra Pedraza, María Queralt Salas, et al. · Transplantation and Cellular Therapy · 23
Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxis
2023 · Silvia Escribano-Serrat, Luis Gerardo Rodríguez-Lobato, et al. · Cytotherapy · 21
The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever
2020 · Luis-Gerardo Rodríguez-Lobato, Alexandra Martínez-Roca, et al. · PLoS ONE · 21
PDF
Works count: 279
Citation count: 1,409
H-index: 23
I10-index: 40
Year
Topic
Type